Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Alefacept showed some effectiveness for alopecia areata but needs more research.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

The document lists various dermatology topics, treatments, and diagnostic methods.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Social media can help compare the effectiveness and safety of new arthritis medications.

JAK inhibitors show promise for treating various skin diseases.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.